Anthera Pharmaceuticals Inc 4
4 · Anthera Pharmaceuticals Inc · Filed Jul 2, 2013
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Tax Payment
Common Stock
2013-06-30$0.49/sh−2,248$1,102→ 75,074 total
Holdings
- 99,937(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares forfeited in lieu of payment of tax liability in connection with the vesting of 5,000 performance shares, which represent the portion of the Reporting Person's 2010 performance share award.